• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

明胶-锌载体作为利塞膦酸盐靶向控释的新方法。

Gelatin-Zinc Carrier as a New Method of Targeted and Controlled Release of Risedronate.

作者信息

Reczkowski Jakub, Długosz Maria, Ratajczak Maria, Voelkel Adam, Sandomierski Mariusz

机构信息

Institute of Chemical Technology and Engineering, Poznan University of Technology, ul. Berdychowo 4, 60-965 Poznań, Poland.

Institute of Building Engineering, Poznan University of Technology, ul. Piotrowo 5, 60-965 Poznań, Poland.

出版信息

Materials (Basel). 2024 May 21;17(11):2473. doi: 10.3390/ma17112473.

DOI:10.3390/ma17112473
PMID:38893737
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11172601/
Abstract

The essence of drug delivery is to use an appropriate carrier that delivers the active substance to the appropriate pathogenic site at a specific time. This study aims to develop a novel drug carrier characterized by the controlled and targeted release of risedronate (RSD). The search for new routes to deliver RSD is important because oral delivery has many disadvantages. The carrier proposed in this work is composed of gelatin, polyphosphates, and zinc. The zinc contained in the carrier is responsible for coordinating the drug. The resulting material releases RSD in a controlled manner. The rate of delivery of the substance to the body depends on the pH of the environment. This study investigated the delivery of RSD in a neutral environment, where the process exhibited a prolonged and consistent release rate. This process has also been studied in an acidic environment, which accelerates the release of the drug. Mixed-environment studies were also conducted. Initially, the drug was released in a neutral environment, and then the conditions rapidly changed to acidic. In this case, the carrier demonstrated high stability and controlled release, adapting the rate of drug release to the prevailing environmental conditions. The presented results indicate the great potential of the new gelatin-based carrier in the delivery of risedronate.

摘要

药物递送的本质是使用合适的载体,在特定时间将活性物质递送至合适的致病部位。本研究旨在开发一种以利塞膦酸盐(RSD)的控释和靶向释放为特征的新型药物载体。寻找递送RSD的新途径很重要,因为口服给药有许多缺点。本研究中提出的载体由明胶、多磷酸盐和锌组成。载体中含有的锌负责与药物配位。所得材料以可控方式释放RSD。该物质向体内的递送速率取决于环境的pH值。本研究在中性环境中研究了RSD的递送,该过程呈现出延长且一致的释放速率。该过程也在酸性环境中进行了研究,酸性环境会加速药物释放。还进行了混合环境研究。最初,药物在中性环境中释放,然后条件迅速变为酸性。在这种情况下,载体表现出高稳定性和控释性,使药物释放速率适应主要的环境条件。所呈现的结果表明新型明胶基载体在递送利塞膦酸盐方面具有巨大潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/708bc4f42e1d/materials-17-02473-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/f1a0696fd95c/materials-17-02473-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/f520046ce8eb/materials-17-02473-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/e0615c8d3eb5/materials-17-02473-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/b2e278a42a87/materials-17-02473-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/9644ab5f8d00/materials-17-02473-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/da43d52fa0f9/materials-17-02473-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/99c0a2ff74ad/materials-17-02473-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/b8c273335162/materials-17-02473-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/9dded25698c9/materials-17-02473-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/b2d2b8da9238/materials-17-02473-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/127c0ec27865/materials-17-02473-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/708bc4f42e1d/materials-17-02473-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/f1a0696fd95c/materials-17-02473-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/f520046ce8eb/materials-17-02473-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/e0615c8d3eb5/materials-17-02473-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/b2e278a42a87/materials-17-02473-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/9644ab5f8d00/materials-17-02473-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/da43d52fa0f9/materials-17-02473-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/99c0a2ff74ad/materials-17-02473-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/b8c273335162/materials-17-02473-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/9dded25698c9/materials-17-02473-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/b2d2b8da9238/materials-17-02473-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/127c0ec27865/materials-17-02473-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e070/11172601/708bc4f42e1d/materials-17-02473-g012.jpg

相似文献

1
Gelatin-Zinc Carrier as a New Method of Targeted and Controlled Release of Risedronate.明胶-锌载体作为利塞膦酸盐靶向控释的新方法。
Materials (Basel). 2024 May 21;17(11):2473. doi: 10.3390/ma17112473.
2
Zinc-doped hydroxyapatite as a pH responsive drug delivery system for anticancer drug 6-mercaptopurine.锌掺杂羟基磷灰石作为一种 pH 响应型药物输送系统,用于抗癌药物 6-巯基嘌呤。
J Biomed Mater Res B Appl Biomater. 2024 Mar;112(3):e35395. doi: 10.1002/jbm.b.35395.
3
Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.用于细胞内酸触发药物递送的天然明胶封端介孔硅纳米粒子。
Langmuir. 2013 Oct 15;29(41):12804-10. doi: 10.1021/la4022646. Epub 2013 Oct 3.
4
Carbon Dot Cross-Linked Gelatin Nanocomposite Hydrogel for pH-Sensing and pH-Responsive Drug Delivery.碳点交联明胶纳米复合水凝胶用于 pH 传感和 pH 响应型药物传递。
ACS Biomater Sci Eng. 2020 Oct 12;6(10):5662-5674. doi: 10.1021/acsbiomaterials.0c00982. Epub 2020 Sep 30.
5
Diisocyanate mediated polyether modified gelatin drug carrier for controlled release.二异氰酸酯介导的聚醚改性明胶药物载体用于控制释放。
Saudi Pharm J. 2014 Jan;22(1):43-51. doi: 10.1016/j.jsps.2013.01.005. Epub 2013 Jan 26.
6
Drug distribution evaluation using FT-IR imaging on the surface of a titanium alloy coated with zinc titanate with potential application in the release of drugs for osteoporosis.采用 FT-IR 成像技术对涂有钛酸锌的钛合金表面进行药物分布评估,该技术具有在骨质疏松症药物释放方面的潜在应用。
Spectrochim Acta A Mol Biomol Spectrosc. 2022 Nov 15;281:121575. doi: 10.1016/j.saa.2022.121575. Epub 2022 Jul 2.
7
Mesoporous Silica Modified with Polydopamine and Zinc Ions as a Potential Carrier in the Controlled Release of Mercaptopurine.聚多巴胺和锌离子修饰的介孔二氧化硅作为巯嘌呤控释的潜在载体
Materials (Basel). 2023 Jun 13;16(12):4358. doi: 10.3390/ma16124358.
8
Pharmaceutical approaches to colon targeted drug delivery systems.结肠靶向给药系统的药物学方法。
J Pharm Pharm Sci. 2003 Jan-Apr;6(1):33-66.
9
Incorporating Cu-based metal-organic framework/drug nanohybrids into gelatin microsphere for ibuprofen oral delivery.将基于铜的金属有机骨架/药物纳米杂化物纳入明胶微球中用于布洛芬口服递送。
Mater Sci Eng C Mater Biol Appl. 2019 Mar;96:302-309. doi: 10.1016/j.msec.2018.11.028. Epub 2018 Nov 22.
10
Release of drugs used in the treatment of osteoporosis from zeolites with divalent ions-Influence of the type of ion and drug on the release profile.沸石中用于治疗骨质疏松症的药物释放-离子类型和药物对释放特性的影响。
J Biomed Mater Res B Appl Biomater. 2023 May;111(5):1005-1014. doi: 10.1002/jbm.b.35209. Epub 2022 Nov 30.

本文引用的文献

1
Crosslinked Chitosan-Gelatin Biocompatible Nanocomposite as a Neuro Drug Carrier.交联壳聚糖-明胶生物相容性纳米复合材料作为神经药物载体
ACS Omega. 2022 May 26;7(22):18732-18744. doi: 10.1021/acsomega.2c01443. eCollection 2022 Jun 7.
2
Controlled release of the drug for osteoporosis from the surface of titanium implants coated with calcium titanate.药物从涂有钛酸钙的钛植入物表面实现骨质疏松症药物的控释。
J Biomed Mater Res B Appl Biomater. 2022 Feb;110(2):431-437. doi: 10.1002/jbm.b.34919. Epub 2021 Jul 21.
3
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus.
颌骨骨坏死的诊断和治疗:系统评价和国际共识。
J Bone Miner Res. 2015 Jan;30(1):3-23. doi: 10.1002/jbmr.2405.
4
Facile one-pot preparation of chitosan/calcium pyrophosphate hybrid microflowers.壳聚糖/焦磷酸钙杂化微花的简便一锅法制备
ACS Appl Mater Interfaces. 2014 Aug 27;6(16):14522-32. doi: 10.1021/am503787h. Epub 2014 Aug 4.
5
Effect of zinc ions on improving implant fixation in osteoporotic bone.锌离子对改善骨质疏松性骨中种植体固定的作用。
Connect Tissue Res. 2013;54(4-5):290-6. doi: 10.3109/03008207.2013.813495. Epub 2013 Aug 23.
6
Biomedical applications of bisphosphonates.双膦酸盐在生物医药中的应用。
J Control Release. 2013 Apr 28;167(2):175-88. doi: 10.1016/j.jconrel.2013.01.032. Epub 2013 Feb 8.
7
Alterations in osteoclast function and phenotype induced by different inhibitors of bone resorption--implications for osteoclast quality.不同骨吸收抑制剂诱导的破骨细胞功能和表型改变——对破骨细胞质量的影响。
BMC Musculoskelet Disord. 2010 Jun 1;11:109. doi: 10.1186/1471-2474-11-109.
8
Gelatin-based delivery systems for cancer gene therapy.基于明胶的癌症基因治疗递药系统。
J Drug Target. 2009 Dec;17(10):731-8. doi: 10.3109/10611860903096540.
9
Common buffers, media, and stock solutions.常用缓冲液、培养基和储备溶液。
Curr Protoc Hum Genet. 2001 May;Appendix 2:Appendix 2D. doi: 10.1002/0471142905.hga02ds26.
10
Preparation and FT-IR characterization of metal phytate compounds.金属植酸盐化合物的制备及傅里叶变换红外光谱表征
J Environ Qual. 2006 Jul 6;35(4):1319-28. doi: 10.2134/jeq2006.0008. Print 2006 Jul-Aug.